Usana Health Sciences Inc 8-K, filed May 5, 2020
Usana Health Sciences Inc (USNA)
8-K
2020-05-05
For: 2020-05-01
View Original
Added on
April 06, 2026
About this 8-K
Usana Health Sciences Inc filed this 8-K on May 5, 2020, reporting on events of May 1, 2020.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
|
|
|
|
|
(Commission File No.)
|
(IRS Employer
Identification No.)
|
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801 ) 954-7100
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of
Matters to a Vote of Security Holders.
The Company held its Annual Meeting of Shareholders on May 1, 2020. A total of 19,166,421shares (approximately 88.94%) of the issued and outstanding
shares of USANA common stock were represented by proxy or in person at the meeting. The following matters were submitted and voted upon at the Annual Meeting:
| 1. |
USANA shareholders voted to elect seven individuals to the Board of Directors for the succeeding year as set forth below:
|
|
Name
|
|
Number of
Shares For
|
Number
of Shares
Withheld
|
Number
of Shares
Abstaining
|
Broker
Non-Votes
|
|||
|
|
|
|
|
|
|
|
|
|
|
Kevin G. Guest
|
|
17,461,603
|
|
362,746
|
|
-
|
|
1,342,072
|
|
Robert Anciaux
|
|
17,747,115
|
|
77,234
|
|
-
|
|
1,342,072
|
|
Gilbert A. Fuller
|
|
17,420,525
|
|
403,824
|
|
-
|
|
1,342,072
|
|
Feng Peng
|
|
17,651,114
|
|
173,235
|
|
-
|
|
1,342,072
|
|
Peggie J. Pelosi
|
|
17,629,216
|
|
195,133
|
|
-
|
|
1,342,072
|
|
Frederic Winssinger
|
|
17,560,154
|
|
264,195
|
|
-
|
|
1,342,072
|
|
Timothy E. Wood, Ph. D.
|
|
17,753,476
|
|
70,873
|
|
-
|
|
1,342,072
|
| 2. |
USANA shareholders voted to ratify the Board’s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2020 as set forth below:
|
|
Number of
Shares For
|
Number
of Shares
Against
|
Number
of Shares
Abstaining
|
Broker
Non-Votes
|
|||
|
|
|
|
|
|
|
|
|
19,088,754
|
|
36,712
|
|
40,955
|
|
-
|
| 3. |
USANA shareholders voted to approve, on an advisory basis, executive compensation as set forth below:
|
|
Number of
Shares For
|
|
Number
of Shares
Against
|
|
Number
of Shares
Abstaining
|
|
Broker
Non-Votes
|
|
17,422,938
|
|
361,206
|
|
40,205
|
|
1,342,072
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
By: /s/ G. Douglas Hekking
|
|
G. Douglas Hekking, Chief Financial Officer
|
Date: May 5, 2020